University Hospital Tuebingen
Clinical trials sponsored by University Hospital Tuebingen, explained in plain language.
-
Clot-Busting drug may save sight after eye stroke
Disease control TerminatedThis study tested whether a clot-dissolving medicine (alteplase) given within 4.5 hours of a central retinal artery occlusion (eye stroke) can restore vision. About 127 adults with sudden, painless vision loss in one eye were enrolled. The trial was stopped early, but results may…
Phase: PHASE3 • Sponsor: University Hospital Tuebingen • Aim: Disease control
Last updated Jun 02, 2026 11:59 UTC
-
Catheter use after stroke may trigger confusion in older men
Knowledge-focused TerminatedThis study aimed to see if having a urinary catheter after a stroke increases the chance of delirium (sudden confusion) in men aged 70 and older. Researchers planned to follow 50 patients for 10 days after stroke treatment. The study was stopped early, so results are limited.
Phase: NA • Sponsor: University Hospital Tuebingen • Aim: Knowledge-focused
Last updated Jun 16, 2026 12:51 UTC